Nutraceutical Combination in Patients With Low-grade Systemic Inflammation

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

February 28, 2015

Conditions
AtherosclerosisInflammationHypercholesterolemia
Interventions
DIETARY_SUPPLEMENT

Nutraceutical Combination

red yeast rice extract 200 mg (equivalent to 3 mg monacolins), policosanol 10 mg, berberine 500 mg, 0.2 mg folic acid, coenzyme Q10 2 mg, and astaxanthin 0.5 mg once daily

OTHER

Standard of Care

low-cholesterol/low-saturated fat diet and regular aerobic physical activity schedule

OTHER

Placebo

placebo

All Listed Sponsors
lead

University Of Perugia

OTHER

NCT02422927 - Nutraceutical Combination in Patients With Low-grade Systemic Inflammation | Biotech Hunter | Biotech Hunter